Skip to main content Back to Top
Advertisement

10/11/2019

Metronidazole Hydrochloride Injection

Products Affected - Description

    • Metronidazole hydrochloride solution for injection, Baxter, 5 mg/mL, 100 mL bag, 24 count, NDC 36000-0001-24

Reason for the Shortage

    • Baxter did not provide a reason for the shortage.
    • BBraun has metronidazole injection available.
    • Pfizer has metronidazole injection available.
    • Sagent launched metronidazole injection in October 2019.

Available Products

    • Metronidazole hydrochloride solution for injection, BBraun, 5 mg/mL, 100 mL bag, 24 count, NDC 00264-5535-32
    • Metronidazole hydrochloride solution for injection, Baxter, 5 mg/mL, 100 mL bag, 24 count, NDC 00338-1055-48
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 24 count, NDC 00409-7811-24
    • Metronidazole hydrochloride solution for injection, Pfizer, 5 mg/mL, 100 mL bag, 80 count, NDC 00409-7811-37
    • Metronidazole hydrochloride solution for injection, Sagent, 5 mg/mL, 100 mL bag, 24 count, NDC 25021-0131-82

Estimated Resupply Dates

    • Baxter has metronidazole 100 mL bags (NDC 36000-0001-24) on back order and the company cannot estimate a release date.

Updated

Updated October 11, 2019 by Leslie Jensen, PharmD, Drug Information Specialist. Created May 8, 2017 by Leslie Jensen, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins